Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for Weight Loss and Gastric Functions in Obesity
NCT02647944Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Dec 2015
- Primary completion
- Dec 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in obesity, sponsored by Mayo Clinic. Started Dec 2015; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02647944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02647944.